5 research outputs found
Deprescribing recommendations: an essential consideration for clinical guideline developers
One area of
focus of the Bruyère Evidence-Based Deprescribing Guidelines Symposium held in
March 2018 was encouraging the routine inclusion of deprescribing
recommendations in clinical guidelines. Clinical guidelines often do not
accommodate frailty or patients with multiple comorbid conditions. This can
give rise to complex medication regimens and risk of medication harm. Despite
monitoring and stopping treatment being a key part of rational prescribing, deprescribing is often overlooked in general and in the context of guidelines. There
are several challenges to increasing deprescribing recommendations in clinical
guidelines. These include limited evidence on the effects of deprescribing,
lack of awareness among guideline developers, potential conflicts of interest,
and lack of incentives for deprescribing research. To date, medicines
regulators, payers, governments, and journals have not encouraged the inclusion
of deprescribing recommendations in guidelines. The Grading of Recommendations
Assessment, Development and Evaluation (GRADE) system could address some of
these challenges through its focus on values and preferences, distinct rating
of quality of evidence and strength of recommendations, downgrading quality due
to indirect evidence, and an explicit approach to conflicts of interest.
Further work to adapt GRADE methods to deprescribing could be of benefit.
Establishing deprescribing recommendations as a routine part of clinical
guidelines is an important opportunity to improve evidence-based clinical
practice, and ultimately, patient care.</p
Lack of Evidence to Guide Deprescribing of Antihyperglycemics: A Systematic Review
<p><strong>Article full
text</strong></p>
<p><br>
The full text of this article can be found <a href="https://link.springer.com/article/10.1007/s13300-016-0220-9"><b>here</b>.</a><br>
<br>
<strong>Provide enhanced digital features for this article</strong><br>
If you are an author of this publication and would like to provide additional enhanced
digital features for your article then please contact <u>[email protected]</u>.<br>
<br>
The journal offers a range of additional features designed to increase
visibility and readership. All features will be thoroughly peer reviewed to ensure the content is of the
highest scientific standard and all features are marked as ‘peer reviewed’ to
ensure readers are aware that the content has been reviewed to the same level
as the articles they are being presented alongside. Moreover, all sponsorship
and disclosure information is included to provide complete transparency and
adherence to good publication practices. This ensures that however the content
is reached the reader has a full understanding of its origin. No fees are
charged for hosting additional open access content.<br>
<br>
Other enhanced features include, but are
not limited to:<br>
• Slide decks<br>
• Videos and animations<br>
• Audio abstracts<br>
• Audio slides<u></u></p>
<p> </p>
<p> </p>
<p> </p
Additional file 1: of The Aging, Community and Health Research Unit—Community Partnership Program for older adults with type 2 diabetes and multiple chronic conditions: a feasibility study
STROBE Statement—checklist of items that should be included in reports of observational studies. (PDF 31 kb